{
  "author": {
    "name": "Jay Hancock Kaiser Health News Shefali Luthra Kaiser Health News",
    "webUrl": "/author/profile/jay-hancock-kaiser-health-news-shefali-luthra-kaiser-health-news/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2018/02/01/as-states-target-drug-costs-big-pharma-targets-sta/",
        "title": "As states target drug costs, Big Pharma targets states",
        "byline": " Jay Hancock, Kaiser Health News, Shefali Luthra, Kaiser Health News ",
        "kicker": "",
        "prettyDate": "February 01, 2018",
        "timeToRead": "7 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/jay-hancock-kaiser-health-news-shefali-luthra-kaiser-health-news/",
            "name": "Jay Hancock, Kaiser Health News, Shefali Luthra, Kaiser Health News"
          }
        ],
        "kickerNode": [],
        "summary": "With federal officials seemingly unwilling or unable to come up with legislation to control skyrocketing drug prices, that task is increasingly moving to the states. But so is pharma muscle and money.",
        "body": null
      }
    ]
  }
}